Sentences with phrase «of oclacitinib»
«Efficacy and safety of oclacitinib (APOQUEL) compared to prednisolone for the control of pruritus and clinical signs associated with allergic dermatitis in client - owned dogs»
https://www.zoetisus.com/
«Efficacy and safety of oclacitinib (APOQUEL) compared to cyclosporine (Atopica, Novartis Animal Health) for the control of atopic dermatitis in client - owned dogs»
About the Study The study, «Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis,» was conducted as a double - masked, placebo - controlled clinical trial aimed to evaluate the safety and efficacy of APOQUEL compared with placebo.
Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis.
Long - term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of life.
Not exact matches
Recent advancements have been made in the area of antipruritic medications for animals and there are now effective medications with fewer long term side effects such as cyclosporine (Atopica) and oclacitinib (Apoquel).
A blinded, randomized, placebo - controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel ®) in client - owned dogs with atopic dermatitis.
APOQUEL (oclacitinib tablet) is a prescription allergy medicine that provides fast, effective, and safe relief of allergic dog itch.
Find out more information about the causes of allergic dog itch, APOQUEL (oclacitinib tablet) allergy medicine, how to track the signs, and what to ask your veterinarian right here.
Florham Park, N.J. — August 13, 2013 — Results of a new pivotal study show that APOQUEL ® (oclacitinib tablet) provides effective and safe control of pruritus associated with allergic dermatitis in dogs with a rapid onset of efficacy within 24 hours and without the commonly reported side effects of steroids.
Jennifer Schissler Pendergraft, DVM, MS, DACVD, and co-investigator Andrew Simpson, DVM, of Colorado State University James L. Voss Veterinary Teaching Hospital, will receive a grant for their project, «Frequency of urinary tract infection in dogs treated with oclacitinib (APOQUEL) for cutaneous hypersensitivity: a prospective study.»
Certain medications the dog might be receiving concurrently (spinosad / Comfortis ®, antifungals medications like itraconazole and ketoconazole, certain antibiotics, corticosteroids, Apoquel ® / oclacitinib, etc.) can make a bad reaction to the avermectins more likely You can read more on the subject of demodectic mange treatment here, here, here and here.